NCT06737393 Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge
| NCT ID | NCT06737393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Tennessee |
| Condition | Patient Discharge |
| Study Type | INTERVENTIONAL |
| Enrollment | 112 participants |
| Start Date | 2025-01-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 112 participants in total. It began in 2025-01-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators hypothesize that backfilling the bladder postoperatively will reduce time to spontaneous void and subsequent discharge from the post-anesthesia care unit.
Eligibility Criteria
Inclusion Criteria: * Women aged 18 to 80 * Undergoing planned laparoscopic hysterectomy as a day surgery procedure Exclusion Criteria: * Women younger than 18 or older than 80 years of age * Undergoing a non-laparoscopic unplanned surgical procedure
Frequently Asked Questions
Who can join the NCT06737393 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Patient Discharge. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06737393 currently recruiting?
Yes, NCT06737393 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Tennessee to inquire about joining.
Where is the NCT06737393 trial being conducted?
This trial is being conducted at Memphis, United States.
Who is sponsoring the NCT06737393 clinical trial?
NCT06737393 is sponsored by University of Tennessee. The trial plans to enroll 112 participants.